US health chief skeptical of Russia’s virus vaccine claim

first_img“It’s important that we provide safe, effective vaccines and that the data be transparent… This is not a race to be first,” he told reporters during a conference call.”I should note that two of the six US vaccines that we’ve invested in entered the phase three clinical trials weeks ago that the Russian vaccine is now only beginning,” he added.”The data from the initial trials in Russia have not been disclosed, it’s not transparent.”Russian President Vladimir Putin said the vaccine was safe, and that one of his daughters had received a dose. The vaccine has been named “Sputnik”, after the world’s first artificial satellite that helped the Soviet Union take the lead in the Cold War space race in 1957.Governments are under huge pressure to find a vaccine against the coronavirus, which has killed more than 700,000 people worldwide and eviscerated the global economy since it first emerged in central China late last year.The United States is the worst-hit country, with nearly 5.1 million infections and more than 163,000 deaths.President Donald Trump is facing a tough fight to get re-elected in November, trailing rival Joe Biden in the polls as anger mounts over his administration’s response to the pandemic.Azar said he was confident a vaccine would be available for Americans.”We believe that it is highly credible that we will have in the high tens of millions of doses of gold-standard, safe and effective vaccine by the end of this year, and many hundreds of millions of doses as we go into the beginning of next year,” he said.Trump has launched “Operation Warp Speed”, which aims to develop, manufacture and distribute a coronavirus vaccine to all Americans by January 2021.So far, Washington has handed out at least $9.4 billion to seven vaccine developers and signed manufacturing contracts with five of them to provide 700 million doses.Azar’s Taiwan trip — the highest-level US visit since Washington switched diplomatic recognition to Beijing in 1979 — was billed as an opportunity to learn from the island’s success in containing the virus.Taiwan has reported fewer than 500 infections and just seven COVID-19 deaths. Topics :center_img Washington’s health chief on Wednesday expressed skepticism about Russia’s claim of developing the world’s first safe coronavirus vaccine, pointing to the lack of data from its initial trials.Moscow said Tuesday its vaccine offered “sustainable immunity” against the virus, but Western scientists have previously raised concerns about the development speed of Russian treatments, suggesting researchers were cutting corners.US Health Secretary Alex Azar echoed those concerns Wednesday as he wrapped up a three-day visit to Taiwan.last_img read more

California-Bred Warren’s Showtime Smokes Late To Take $75,000 China Doll Stakes By A Half Length

first_imgCalifornia-Bred Warren’s Showtime Smokes Late To Take $75,000 China Doll Stakes By A Half Length; Warren Homebred, Ridden By Velez & Trained By Lewis, Gets Mile On Turf 1:36.24 ARCADIA, Calif. (March 7, 2020)–Mid-pack among a field of 13 sophomore fillies heading to the far turn, Benjamin and Sally Warren’s homebred Warren’s Showtime somehow found room a furlong from home and roared up the rail to take Saturday’s $75,000 China Doll Stakes by a half length.  A California-bred daughter of red hot sire Clubhouse Ride, Warren’s Showtime, who was ridden by apprentice Jorge Velez and is trained by Craig Lewis, got a mile on turf in 1:36.24.A winner of the California Cup Oaks at one mile on turf here Jan. 18, Warren’s Showtime was off as the narrow 3-1 favorite over highly regarded Irish-bred Stela Star and paid $8.00, $4.20 and $3.00.Out of Warren’s Grade I winning Affirmative mare Warren’s Veneda, Warren’s Showtime picked up her third stakes win, all in combination with Velez, and registered her fourth overall win from seven starts.  With the winner’s share of $45,000, she now has earnings of $281,271.Ridden by Joel Rosario and trained by John Sadler, Stela Star was the second choice at 3-1, as she attracted roughly $900.00 less than the winner, returning $4.80 and $3.60.Head and head for the lead with longshot Roadrunner’s Honor to the far turn, Bella Vita spurted two lengths clear a furlong out, but was no match for the top two late.  Ridden by Flavien Prat, California-bred Bella Vita was off at 4-1 and paid $3.80 to show.Fractions on the race were 23.43, 47.84, 1:12.30 and 1:24.37.last_img read more